Back to top

genetics: Archive

Bryan Hayes

BioPharma Giants Print Fresh All-Time Highs

The trend is our friend in this market, and these two biopharmaceutical stocks are trending exceptionally well.

REGNPositive Net Change BMYNegative Net Change

Bryan Hayes

Bull of the Day: Pfizer Inc. (PFE)

With a dividend yield of 3% and a top Zacks VGM score of 'A', it's not hard to see why PFE is a top stock pick.

PFEPositive Net Change

Brian Bolan

Bull Of The Day: Cutera (CUTR)

This maker of lasers is posting some impressive growth and earnings numbers.

CUTRNegative Net Change

Kevin Cook

Bull of the Day: Vertex Pharmaceuticals (VRTX)

Scientific innovation in the treatment of cystic fibrosis bolsters success and pipeline confidence

VRTXNegative Net Change MRNANegative Net Change CRSPNegative Net Change

Kevin Cook

Bear of the Day: NeoGenomics (NEO)

Emerging diagnostics provider is steadily growing sales and key M&A but ran into an EPS cliff

NEONegative Net Change EXASNegative Net Change NVTANegative Net Change NTRANegative Net Change GHNegative Net Change

Kevin Cook

Bear of the Day: Vericel (VCEL)

Restoring cartilage in sports medicine and rebuilding skin after severe burns gave this small-cap big upside

VCELNegative Net Change UNHPositive Net Change MDWDPositive Net Change

Kevin Cook

Bull of the Day: Exact Sciences (EXAS)

EPS surprises abound as Cologuard and Precision Oncology grow sales 20% into next year

EXASNegative Net Change ADPTNegative Net Change NVTANegative Net Change NTRANegative Net Change GHNegative Net Change

Sweta Jaiswal, FRM

A Comprehensive Guide to Genomic ETFs

Genomic ETFs are expected to benefit from the favorable trends in the genomic editing space.

BEAMNegative Net Change EDITNegative Net Change PBENegative Net Change NTLANegative Net Change CRSPNegative Net Change ARKGNegative Net Change GNOMNegative Net Change IDNANegative Net Change

Sweta Jaiswal, FRM

Genomics ETFs Surge on a Major Breakthrough in CRISPR Study

The genomic-editing space has come under the spotlight with the release of encouraging data from a study assessing an in vivo CRISPR-based gene editing therapy candidate, NTLA-2001.

REGNPositive Net Change BEAMNegative Net Change EDITNegative Net Change NTLANegative Net Change CRSPNegative Net Change ARKGNegative Net Change GNOMNegative Net Change IDNANegative Net Change

Kevin Cook

Bear of the Day: Guardant Health (GH)

Cancer detection innovator with liquid biopsy saw analysts slash estimates as R&D investment costs rise

GHNegative Net Change EXASNegative Net Change

Zacks Equity Research

Moving Average Crossover Alert: Passage Bio (PASG)

Passage Bio (PASG) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front

PASGNo Net Change

Kevin Cook

Bear of the Day: CRISPR Therapeutics (CRSP)

Gene editors got a big boost recently from sickle cell potential and Cathie Wood's thematic investing

CRSPNegative Net Change EDITNegative Net Change ARKKNegative Net Change NTLANegative Net Change ARKGNegative Net Change

Kevin Cook

Bear of the Day: Illumina (ILMN)

Maker of premier next-gen genomic sequencing technology lowers guidance but shares make new highs

ILMNNegative Net Change EDITNegative Net Change NVTANegative Net Change ARKKNegative Net Change ARKGNegative Net Change

Sweta Jaiswal, FRM

5 Top-Performing ARK ETFs Worth Your Attention Now

Here we highlight some ETFs from the house of ARK Investment Management that have gained more than 100% in the past year for our investors to consider.

TDOCNegative Net Change PYPLPositive Net Change SQNegative Net Change ARKQNegative Net Change ARKWNegative Net Change ARKKNegative Net Change CRSPNegative Net Change ROKUNegative Net Change ARKGNegative Net Change GBTCNegative Net Change ARKFNegative Net Change

Kevin Cook

Bull of the Day: Meridian Bioscience (VIVO)

Small-cap diagnostics player will grow sales 20%+ to over $310 million on COVID-19 testing and its mutations

VIVOPositive Net Change HOLXNegative Net Change QDELNegative Net Change EDITNegative Net Change CRSPNegative Net Change

Daniel Laboe

The Innovative Future Of ETFs

Ark Invest is driving a new generation of actively managed ETFs

TSLANegative Net Change SQNegative Net Change ROKUNegative Net Change PRLBNegative Net Change NVTANegative Net Change CRSPNegative Net Change ARKKNegative Net Change

Sweta Jaiswal, FRM

Genomics ETFs Surge on Nobel Prize for Gene-Editing Pioneers

The announcement of the 2020 Nobel Prize winners for Chemistry has successfully brought investor attention to the gene-editing space.

PBENegative Net Change ARKGNegative Net Change GNOMNegative Net Change IDNANegative Net Change

Madeleine Johnson

Bear of the Day: Illumina (ILMN)

The coronavirus pandemic has dampened this medical stock's earnings and outlook.

TMONegative Net Change ILMNNegative Net Change

Kevin Cook

Bull of the Day: Quidel (QDEL)

Multiple FDA approvals for new 15-minute COVID-19 antigen tests have estimates and shares rising sharply

QDELNegative Net Change MRNANegative Net Change

Sweta Jaiswal, FRM

Profit from the Genomics Market Momentum With These ETFs

Here we highlight some ETFs for gaining exposure to the genomics market that is currently buzzing with opportunities for investors to cash on.

GSKPositive Net Change PBENegative Net Change ARKGNegative Net Change GNOMNegative Net Change IDNANegative Net Change

Kevin Cook

Bull of the Day: Vertex Pharma (VRTX)

While COVID-19 interrupts clinical trials, the champ of cystic fibrosis is about to repeat another year of 37% revenue growth

VRTXNegative Net Change CRSPNegative Net Change